Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
06/28/1995 | EP0659192A1 Novel antibodies for conferring passive immunity against infection by a pathogen in humans |
06/28/1995 | EP0659045A1 Genetically engineered mice containing alterations in the genes encoding retinoic acid receptor proteins |
06/28/1995 | EP0642350A4 Method for modifying, diagnosing, and screening for igf-i sensitive cell barrier properties. |
06/28/1995 | EP0625157A4 PLATELET GPIIIa P1?A1 AND P1?A2 EPITOPES, THEIR PREPARATION AND USE. |
06/28/1995 | EP0552280B1 Inhibition of viral replication |
06/28/1995 | EP0539405B1 Peptides and analogues and mixtures thereof for detecting antibodies to htlv-i and htlv-ii viruses |
06/28/1995 | EP0533750B1 High molecular weight dna compositions for use in electrophoresis of large nucleic acids |
06/28/1995 | EP0514494B1 Method for detection of human immunodeficiency virus and cell lines useful therefor |
06/28/1995 | EP0513073B1 PROCESS FOR ENZYMATICAL CLEAVAGE OF RECOMBINANT PROTEINS BY MEANS OF IgA PROTEASES |
06/28/1995 | EP0510091B1 An enzyme exhibiting cellulase activity |
06/28/1995 | EP0494268B1 Method for inhibiting growth of stem cells |
06/28/1995 | EP0460171B1 Cd3 specific recombinant antibody |
06/28/1995 | EP0457758B1 Tissue plasminogen activator having zymogenic or fibrin specific properties |
06/28/1995 | EP0432220B1 Vaccines and diagnostic assays for haemophilus influenzae |
06/28/1995 | CN1104255A Method for preparation of 7-amino cephaloalkyl acid by one step and two enzyme method |
06/28/1995 | CN1104253A Plasmid derived from lactobacillus delbrueckii SP. |
06/28/1995 | CN1104252A Nucleic acid markers for rice blast resistance genes and rice blast resistance genes isolated by the use of these markers |
06/28/1995 | CN1104251A Nucleic acid markers for rice blast resistance genes and rice blast resistance genes isolated by the use of these markers |
06/27/1995 | US5428147 Octopine T-DNA promoters |
06/27/1995 | US5428146 Wound-stimulated DNA-sequence from solanum tuberosum and its use |
06/27/1995 | US5428144 Isolation of coat protein gene and incorporation into an expression cassette for the plant cell system; transformed vetor introduced into maize callus to provide cross-protection against viral infection |
06/27/1995 | US5428135 Production of platelet-derived growth factor B-chain heterodimers from high expression host cell system |
06/27/1995 | US5428132 Conjugate and method for integration of foreign DNA into cells |
06/27/1995 | US5428130 Cell surface adhesion molecules and ligands |
06/27/1995 | US5428012 Oncostatin M and novel compositions having anti-neoplastic activity |
06/27/1995 | US5428010 Biologically active B-chain homodimers |
06/27/1995 | US5428007 Increasing oxygenation in hypoxic cells of normal and tumor tissue |
06/27/1995 | US5428001 Applying cyclohexanedione herbicide, a phenoxypropanoic acid herbicide or a mixture thereof; tolerance to inhibition is conferred by an acetyl coenzyme A carboxylase activity |
06/27/1995 | US5427942 Human D5 dopamine recepltor gene and uses |
06/27/1995 | US5427940 Engineered cells producing insulin in response to glucose |
06/27/1995 | US5427939 Expression vectors encoding alloantigens of glycoprotein Ibα |
06/27/1995 | US5427936 Have high activity in alkaline ph range at temperatures between 30 degrees and 40 degrees centigrade; washing compounds |
06/27/1995 | US5427934 Genetic engineering process for the production of S-(+)-2,2-dimethylcyclopropanecarboxamide by microorganisms |
06/27/1995 | US5427930 Amplification of target nucleic acids using gap filling ligase chain reaction |
06/27/1995 | US5427929 Method for reducing carryover contamination in an amplification procedure |
06/27/1995 | US5427928 Thermostable DNA Topoisomerase V |
06/27/1995 | US5427927 Modifying junction region between two components of fusion protein to form immunoglobulin A protease recognition site, cleaving, isolating component |
06/27/1995 | US5427926 Anticoagulant; sulfated glycoprotein |
06/27/1995 | US5427925 Recombniant method for making leukemia inhibitor factor |
06/27/1995 | US5427924 Gene regulation cassettes, expression vectors containing the same and microorganisms transformed with the same |
06/27/1995 | US5427922 DNA encoding a new angiotensin II type 1 receptor subtype and its expression |
06/27/1995 | US5427910 Method of cytogenetic analysis |
06/27/1995 | US5427908 Transforming cell with filamentous bacteriophage expression vector, culturing for expression and assembly of particle with antibody Fab fragment on coat, selecting encoding particle by binding to specific ligand, removing nonbinding particles |
06/27/1995 | US5427792 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus |
06/27/1995 | US5427788 Pertussis toxin and use in vaccines |
06/27/1995 | US5427785 Rhizosheric bacteria |
06/27/1995 | CA1336075C Vector comprising a replication competent hiv-1 provirus and a heterologous gene |
06/25/1995 | CA2138823A1 Carrot 16 kd protein, gene coding for said protein and plasmid containing said gene |
06/23/1995 | CA2138871A1 Modified promoter for rna polymerase, process for preparing the same and applications |
06/23/1995 | CA2138099A1 Enzymatic conversion of proteins using immobilized dictyostelium dipeptidylaminopeptidase |
06/22/1995 | WO1995016913A1 Method of identifying substances with a potential herbicidal or growth-regulatory action by means of vegetable transporter proteins, use of such transporter proteins for this purpose, and substances with a herbicidal or growth-regulatory action identified by the method |
06/22/1995 | WO1995016793A1 Compositions and methods relating to dna mismatch repair genes |
06/22/1995 | WO1995016784A1 Human interferon expression vectors for treating aids |
06/22/1995 | WO1995016783A1 Controlled expression of transgenic constructs in plant plastids |
06/22/1995 | WO1995016782A1 Novel cellulase enzymes and systems for their expression |
06/22/1995 | WO1995016781A1 Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis |
06/22/1995 | WO1995016780A1 Antiviral composition of viral protein trans-dominant variants |
06/22/1995 | WO1995016779A1 Herpes-symplex-virus type 2 icp4 protein and its use in a vaccine composition |
06/22/1995 | WO1995016778A1 Control of aphids with bacillus thuringiensis toxin proteins |
06/22/1995 | WO1995016777A1 Purification of insulin-like growth factor |
06/22/1995 | WO1995016776A1 Derivatives of tachyplesin having inhibitory activity towards plant pathogenic fungi |
06/22/1995 | WO1995016775A1 Tumor cell fusions and methods for use of such tumor cell fusions |
06/22/1995 | WO1995016774A1 Method for inducing dna synthesis in neurons |
06/22/1995 | WO1995016772A1 Adenovirus gene expression system |
06/22/1995 | WO1995016770A1 Ungulate preblastocyst derived embryonic stem cells and use thereof to produce cloned transgenic and chimeric ungulates |
06/22/1995 | WO1995016708A1 Proinsulin-like compounds |
06/22/1995 | WO1995016694A1 Origin of replication complex genes, proteins and methods |
06/22/1995 | WO1995016466A1 Antisense oligonucleotides to suppress eicosanoid formation |
06/22/1995 | WO1995016462A1 Method for antigen-specific immunoregulation by t-cell alpha chain |
06/22/1995 | WO1995016437A1 Method of transmitting a biologically active material to a cell |
06/22/1995 | WO1995016360A1 An enzyme feed additive and animal feed including it |
06/22/1995 | WO1995016353A1 Systemic gene treatment of connective tissue diseases |
06/22/1995 | WO1995015381A3 Human mutator gene hmsh2 and hereditary non polyposis colorectal cancer |
06/22/1995 | WO1995014781A3 Methods for diagnosing early lyme disease |
06/22/1995 | WO1995014780A3 Human monoclonal antibodies against human cytokines and methods of making and using such antibodies |
06/22/1995 | WO1995013386A3 Tyrosinase-activator protein fusion enzyme |
06/22/1995 | WO1995013380A3 Method and reagent for treatment of arthritic conditions |
06/22/1995 | WO1995011048A3 METHODS AND COMPOSITIONS OF A BIOARTIFICIAL KIDNEY SUITABLE FOR USE IN VIVO OR $i(EX VIVO) |
06/22/1995 | WO1995010617A3 Alpha-1,4-glucan lyase from a fungus, its purification gene cloning and expression in microorganisms |
06/22/1995 | WO1995009241A3 Anti-cancer gene therapy by modulation of immune or inflammatory response |
06/22/1995 | WO1995007992A3 Cloned glutamic acid decarboxylase |
06/22/1995 | WO1995007987A3 Novel proteins/polypeptides and cotransfection plasmids and live recombinant carriers therefor |
06/22/1995 | WO1995006740A3 Medium chain-specific thioesterases |
06/22/1995 | WO1995006735A3 Nucleotide sequences for novel protein tyrosine phosphatases |
06/22/1995 | WO1995003407A3 Oligonucleotides with activity against human immunodeficiency virus |
06/22/1995 | EP0665883A4 Tetracycline repressor-mediated binary regulation system for control of gene expression in transgenic animals. |
06/22/1995 | DE4342769A1 Isolation and cloning of cDNA encoding RNA binding protein (RBP) |
06/22/1995 | CA2179285A1 Compositions and methods relating to dna mismatch repair genes |
06/22/1995 | CA2179168A1 Antisense oligonucleotides to suppress eicosanoid formation |
06/22/1995 | CA2179062A1 Method of identifying substances with a potential herbicidal or growth-regulatory action by means of vegetable transporter proteins, use of such transporter proteins for this purpose, and substances with a herbicidal or growth-regulatory action identified by the method |
06/22/1995 | CA2179018A1 Method for antigen-specific immunoregulation by t-cell alpha chain |
06/22/1995 | CA2178965A1 Origin of replication complex genes, proteins and methods |
06/22/1995 | CA2178950A1 Tumor cell fusions and methods for use of such tumor cell fusions |
06/22/1995 | CA2178636A1 Novel cellulase enzymes and systems for their expression |
06/22/1995 | CA2177269A1 Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis |
06/22/1995 | CA2155929A1 Systemic gene treatment of connective tissue diseases |
06/22/1995 | CA2155844A1 Antiviral composition of viral protein trans-dominant variants |
06/22/1995 | CA2155568A1 Human interferon expression vectors for treating aids |
06/22/1995 | CA2138605A1 Immunoreactive peptides of apo(a) |
06/21/1995 | EP0658630A2 Oligonucleotides for the detection of enterobacteriaceae |